E
Entrada Therapeutics, Inc. (TRDA)
NGM – Real Time Price. Currency in USD
7.12
+0.12 (1.71%)
At close: May 12, 2026, 4:00 PM EDT
7.12
0.00 (0.00%)
Pre-market: May 13, 2026, 5:50 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
7.12
+0.12 (1.71%)
At close: May 12, 2026, 4:00 PM EDT
7.12
0.00 (0.00%)
Pre-market: May 13, 2026, 5:50 AM EDT
No Data
There are no news for this stock.
Company's cash reserves $76.4M significantly exceed its total debt $49.8M, ensuring strong financial flexibility
Total current assets $266.9M exceed Total current liabilities $19.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$41.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 13.90 | 6.05 | 10 | |
| Quick ratio | 13.90 | 5.63 | 10 | |
| Debt to Equity | 0.18 | 0.30 | 9.0 | |
| Debt to Assets | 0.15 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 129M | 211M | 25M | 6M |
| Gross Profit | -2M | 126M | 207M | 21M | 2M |
| Operating Income | -97M | -3M | 47M | -156M | -177M |
| Net Income | -95M | -7M | 66M | -144M | -166M |
| EBITDA | -95M | -321K | 51M | -152M | -173M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 14.58 | -2.4 | 4.5 |
| Next quarter | 332.74 | 7.78 | 8.0 |
| Current year | -23.65 | -14.37 | 1.0 |
| Next year | 50.45 | 8.44 | 8.0 |
| Weighted average score | 5.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -32.63 | -1.4 | -1.05 | -30.44 | 1.0 |
| Y/Y | -95.73 | -128.92 | -126.18 | -5.26 | 1.0 |
| 3y average | 324.82 | 285.2 | 242.28 | -28.06 | 7.8 |
| 5y average | 594.49 | 135.56 | 197.46 | -51.45 | 7.8 |
| Weighted average score | 4.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |